BillionToOne (BLLN) Preferred Stock Liabilities (2024 - 2025)
BillionToOne's (BLLN) quarterly Preferred Stock Liabilities came in at $419.4 million in Q3 2025, little changed year-over-year from $419.4 million in Q3 2024, and little changed quarter-over-quarter from $419.4 million in Q2 2025.
Powered by 
Analysis
BillionToOne (BLLN) Preferred Stock Liabilities (2024 - 2025) Analysis & Trends
BillionToOne has disclosed Preferred Stock Liabilities across 2 years of filings, most recently posting $419.4 million for Q3 2025.
- In Q3 2025, Preferred Stock Liabilities changed 0.0% year-over-year to $419.4 million; the TTM figure through Sep 2025 stood at $419.4 million (changed 0.0% YoY), while the FY2024 annual figure was $419.4 million, up 68.08% from the prior year.
- Preferred Stock Liabilities came in at $419.4 million for Q3 2025 at BillionToOne, roughly flat from $419.4 million in the prior quarter.
- In the past five years, Preferred Stock Liabilities ranged from a high of $419.4 million in Q3 2024 to a low of $419.4 million in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | - |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | - |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | - |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | - |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | - |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | - |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | - |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | - |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | - |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 419.41 Mn |
| Jun 30, 2025 | 419.41 Mn |
| Dec 31, 2024 | 419.41 Mn |
| Sep 30, 2024 | 419.41 Mn |